Description for BiferaRx
BiferaRx™ is a prescription iron supplement. BiferaRx™ is a small oval, film-coated maroon tablet, with black core, debossed and bisected with "AP|85" on one side, and plain on the other.
Each BiferaRx™ tablet contains:
Vitamins
Amount per serving:
Folic Acid 1 mg
B12 (as cyanocobalamin) 25 mcg
Minerals
Iron as PIC (polysaccharide iron complex) 22 mg
as HIP (heme iron polypeptide as Proferrin - bovine source, USDA certified) 6 mg
Inactive Ingredients
Microcrystalline cellulose, croscarmellose sodium, crospovidone, magnesium stearate, silicon dioxide, coating (polyvinyl alcohol, polyethylene glycol, talc, FD&C red no. 40 aluminum lake, titanium
dioxide, FD&C blue no. 2 aluminum lake).
Uses for BiferaRx
BiferaRx™ is a prescription iron supplement indicated for use in improving the nutritional status of iron deficiency.
Dosage for BiferaRx
One tablet daily with or without food or as prescribed by a licensed healthcare provider with prescribing authority.
HOW SUPPLIED
BiferaRx™ tablets are supplied in child-resistant bottles of 90 tablets (NDC 68220-085-90) and as a Professional Sample 5 tablet blister pack (NDC 68220-085-25).
KEEP OUT OF REACH OF CHILDREN.
Storage
Store at controlled room temperature 20°-25°C (68°-77°F). Excursions permitted to 15°-30°C (59°- 86°F). [See current USP]
Dispense in a tight, light-resistant container to protect from light and moisture.
For medical inquiries call toll free 1-888-317-0001. www.BiferaRx.com. Manufactured for: ALAVEN PHARMACEUTICAL LLC, Marietta, GA 30062.Revised: Mar 2010
Side Effects for BiferaRx
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Drug Interactions for BiferaRx
No information provided.
Warnings for BiferaRx
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.
Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Precautions for BiferaRx
Folic acid when administered as a single agent in doses above 0.1mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. While prescribing this nutritional supplement for pregnant women, nursing mothers, or for women prior to conception, their medical condition and other drugs, herbs, and/or supplements consumption should be considered.
Patient Information for BiferaRx
No information provided. Please refer to the WARNINGS and PRECAUTIONS sections.
From 
Healthy Resources
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.